Blog: CEN BIOTECH INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K) –

Item 7.01 Regulation FD Disclosure.

On September 7, 2022, CEN Biotech Inc. (the “Company”) issued a press release
(the “Press Release”). The Press Release announces the commencement of trading
of the Company’s common shares on the OTCQB Venture Market® beginning on
September 8, 2022 and also provides a business update. The Press Release is
furnished hereto as Exhibit 99.1 and is incorporated by reference herein. The
information contained in the Press Release is being furnished and shall not be
deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended, or otherwise subject to the liability of that Section, and shall not
be incorporated by reference into any registration statement or other document
filed under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.   Description
99.1**          Press Release dated September 7,
104           Cover Page Interactive Data File
              (embedded within the Inline XBRL

**Furnished herewith.

© Edgar Online, source Glimpses

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s